Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mathur

Showing results (451-460 of 463) with videos related to

Pageof 47
Sort By:
Nano Letters|December 23, 2017
Magnetically Coated Bioabsorbable Stents for Renormalization of Arterial Vessel Walls after Stent ImplantationJ S Lee, P Han, E Song, et al.
The American Journal of Cardiology|May 15, 1997
Comparison of balloon angioplasty versus debulking devices versus stenting in right coronary ostial lesionsS P Jain, M W Liu, L S Dean, et al.
Journal of Medicinal Chemistry|August 24, 2000
Biphenylsulfonamide endothelin receptor antagonists. 2. Discovery of 4'-oxazolyl biphenylsulfonamides as a new class of potent, highly selective ET(A) antagonistsN Murugesan, Z Gu, P D Stein, et al.
The Journal of Pain|March 17, 2022
Confronting Racism in All Forms of Pain Research: Reframing Study DesignsJanelle E Letzen, Vani A Mathur, Mary R Janevic, et al.
BMJ Open|October 2, 2014
Does a 'direct' transfer protocol reduce time to coronary angiography for patients with non-ST-elevation acute coronary syndromes? A prospective observational studyS M Gallagher, M J Lovell, D A Jones, et al.
The Journal of Pain|December 2, 2022
Antiracism CoaliTION in Pain Research (ACTION-PR): Guiding Principles for Equity in ReportingAnna M Hood, Calia A Morais, Edwin N Aroke, et al.
Heart (British Cardiac Society)|December 1, 2011
Case fatality rates for South Asian and Caucasian patients show no difference 2.5 years after percutaneous coronary interventionD A Jones, K S Rathod, N Sekhri, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 1999
Design and characterization of orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist SB 265123 for prevention of bone loss in osteoporosisM W Lark, G B Stroup, S M Hwang, et al.
Infection|October 2, 2015
Bacteremic pneumococcal pneumonia: clinical outcomes and preliminary results of inflammatory responseJ M Bordon, R Fernandez-Botran, T L Wiemken, et al.
Journal of Medicinal Chemistry|November 2, 2001
Design and synthesis of 4-substituted benzamides as potent, selective, and orally bioavailable I(Ks) blockersJ Lloyd, J B Schmidt, G Rovnyak, et al.
Pageof 47

Showing results (451-460 of 463) with videos related to

Sort By:
Pageof 47
Nano Letters|December 23, 2017
Magnetically Coated Bioabsorbable Stents for Renormalization of Arterial Vessel Walls after Stent ImplantationJ S Lee, P Han, E Song, et al.
The American Journal of Cardiology|May 15, 1997
Comparison of balloon angioplasty versus debulking devices versus stenting in right coronary ostial lesionsS P Jain, M W Liu, L S Dean, et al.
Journal of Medicinal Chemistry|August 24, 2000
Biphenylsulfonamide endothelin receptor antagonists. 2. Discovery of 4'-oxazolyl biphenylsulfonamides as a new class of potent, highly selective ET(A) antagonistsN Murugesan, Z Gu, P D Stein, et al.
The Journal of Pain|March 17, 2022
Confronting Racism in All Forms of Pain Research: Reframing Study DesignsJanelle E Letzen, Vani A Mathur, Mary R Janevic, et al.
BMJ Open|October 2, 2014
Does a 'direct' transfer protocol reduce time to coronary angiography for patients with non-ST-elevation acute coronary syndromes? A prospective observational studyS M Gallagher, M J Lovell, D A Jones, et al.
The Journal of Pain|December 2, 2022
Antiracism CoaliTION in Pain Research (ACTION-PR): Guiding Principles for Equity in ReportingAnna M Hood, Calia A Morais, Edwin N Aroke, et al.
Heart (British Cardiac Society)|December 1, 2011
Case fatality rates for South Asian and Caucasian patients show no difference 2.5 years after percutaneous coronary interventionD A Jones, K S Rathod, N Sekhri, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 19, 1999
Design and characterization of orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist SB 265123 for prevention of bone loss in osteoporosisM W Lark, G B Stroup, S M Hwang, et al.
Infection|October 2, 2015
Bacteremic pneumococcal pneumonia: clinical outcomes and preliminary results of inflammatory responseJ M Bordon, R Fernandez-Botran, T L Wiemken, et al.
Journal of Medicinal Chemistry|November 2, 2001
Design and synthesis of 4-substituted benzamides as potent, selective, and orally bioavailable I(Ks) blockersJ Lloyd, J B Schmidt, G Rovnyak, et al.
Pageof 47